Molecular link mechanisms between inflammation and cancer
DB Vendramini-Costa… - Current pharmaceutical …, 2012 - ingentaconnect.com
Inflammation is part of the body's response to internal and external environmental stimuli
that normally eliminate the aggressor agent and restore the tissue physiology. However …
that normally eliminate the aggressor agent and restore the tissue physiology. However …
Nitric oxide-donating non-steroidal anti-inflammatory drugs: the case of nitroderivatives of aspirin
V Chiroli, F Benedini, E Ongini, P Del Soldato - European journal of …, 2003 - Elsevier
Nitric oxide (NO) acts as a key signalling mechanism in a number of cells and tissues in the
mammalian organism. Modulation of the biosynthesis of NO has emerged to be relevant to …
mammalian organism. Modulation of the biosynthesis of NO has emerged to be relevant to …
Nitric Oxide—Releasing NSAIDs: A Review of Their Current Status
S Fiorucci, E Antonelli, JL Burgaud, A Morelli - Drug safety, 2001 - Springer
Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most widely prescribed drugs
worldwide owing to their anti-inflammatory, antipyretic and analgesic properties. However …
worldwide owing to their anti-inflammatory, antipyretic and analgesic properties. However …
In vitro metabolism of nitric oxide-donating aspirin: the effect of positional isomerism
J Gao, K Kashfi, B Rigas - Journal of Pharmacology and Experimental …, 2005 - ASPET
NO-donating aspirin (NO-ASA) is a potentially important chemopreventive agent against
cancer. Since positional isomerism affects strongly its potency in inhibiting colon cancer cell …
cancer. Since positional isomerism affects strongly its potency in inhibiting colon cancer cell …
Chemopreventive efficacy of naproxen and nitric oxide–naproxen in rodent models of colon, urinary bladder, and mammary cancers
VE Steele, CV Rao, Y Zhang, J Patlolla, D Boring… - Cancer Prevention …, 2009 - AACR
Nonsteroidal anti-inflammatory drugs (NSAID) have been highly effective in preventing
colon, urinary bladder, and skin cancer preclinically, and also in clinical trials of colon …
colon, urinary bladder, and skin cancer preclinically, and also in clinical trials of colon …
Targeting inflammation in cancer prevention and therapy
Inflammation is associated with the development and malignant progression of most
cancers. As most of the cell types involved in cancer-associated inflammation are genetically …
cancers. As most of the cell types involved in cancer-associated inflammation are genetically …
A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro
P Andrews, X Zhao, J Allen, F Li, M Chang - Cancer chemotherapy and …, 2008 - Springer
Purpose Previously, we reported in vitro observations suggesting that ibuprofen is an
effective non-prescription non-steroidal anti-inflammatory drug (NSAID) to reduce the …
effective non-prescription non-steroidal anti-inflammatory drug (NSAID) to reduce the …
A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity
Nonsteroidal anti-inflammatory drugs such as sulindac have shown promising antineoplastic
activity, although toxicity from cyclooxygenase (COX) inhibition and the suppression of …
activity, although toxicity from cyclooxygenase (COX) inhibition and the suppression of …
[HTML][HTML] Non-steroidal anti-inflammatory drugs in prevention of gastric cancer
Y Dai, WH Wang - World journal of gastroenterology: WJG, 2006 - ncbi.nlm.nih.gov
Non-steroidal anti-inflammatory drugs (NSAIDs) including cyclooxygenase 2 (COX-2)
selective inhibitors, are potential agents for the chemoprevention of gastric cancer …
selective inhibitors, are potential agents for the chemoprevention of gastric cancer …
Colon tumor cell growth–inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibition
HN Tinsley, BD Gary, J Thaiparambil, N Li, W Lu… - Cancer Prevention …, 2010 - AACR
Nonsteroidal anti-inflammatory drugs (NSAID) display promising antineoplastic activity, but
toxicity resulting from cyclooxygenase (COX) inhibition limits their clinical use for …
toxicity resulting from cyclooxygenase (COX) inhibition limits their clinical use for …